Seth Rudnick is Director at G1 Therapeutics, Inc. (GTHX). They have made 10 open-market trades across 2 companies since 2016, most recently 2021-06-29.
CIK 0001184420
2 open-market purchases totalling $177K since 2016, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GTHX | SELL | 2021-06-29 | 2021-06-30 | $22.35 | $224K | -12.1% | -21.3% | -30.0% |
| GTHX | SELL · 10b5-1 | 2020-12-24 | 2020-12-29 | $20.10 | $19K | +3.0% | +23.7% | +18.0% |
| GTHX | SELL | 2020-12-22 | 2020-12-23 | $20.27 | $1.3M | -12.5% | +3.6% | +7.5% |
| GTHX | SELL | 2020-12-08 | 2020-12-10 | $20.23 | $777K | +6.1% | -2.3% | +19.8% |
| GTHX | SELL · 10b5-1 | 2020-12-01 | 2020-12-03 | $20.09 | $10K | -0.7% | -7.0% | +12.4% |
| GTHX | SELL | 2018-12-04 | 2018-12-04 | $39.31 | $782K | -16.8% | -45.6% | -36.9% |
| GTHX | SELL | 2018-11-05 | 2018-11-07 | $41.53 | $415K | -14.2% | -26.6% | -54.1% |
| GTHX | SELL | 2018-10-04 | 2018-10-05 | $49.76 | $596K | +5.1% | -3.5% | -58.4% |
| GTHX | SELL | 2018-09-04 | 2018-09-06 | $59.95 | $599K | +4.0% | -27.5% | -42.3% |
| GTHX | SELL | 2018-08-06 | 2018-08-06 | $50.69 | $507K | +11.1% | +16.4% | -17.4% |
| ARLZ | BUY | 2017-03-15 | 2017-03-17 | $2.26 | $34K | -11.8% | -36.5% | -54.9% |
| ARLZ | BUY | 2016-11-11 | 2016-11-15 | $4.77 | $143K | -9.5% | -4.5% | -13.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.